Abstract: The disclosed embodiments provide chemical compositions and methods for inducing sleep, the compositions comprising active ingredients of (i) major cannabinoids, (ii) minor cannabinoids, and (iii) sleep-regulating compound(s) comprising at least 1 mg of melatonin. The major cannabinoids comprise 15 to 135 mg of CBD, up to 5 mg of ?9-THC, where the ratio of the CBD to the ?9-THC is at least 10 to 1. The minor cannabinoids comprise up to 5 mg of CBDv, up to 15 mg of CBN, up to 5 of CBGa, up to 5 mg of CBG, and 0.1 to 5 mg of CBC, where a total amount of the minor cannabinoids is at least 1 mg, and a ratio of the CBD to the minor cannabinoids is at least 5 to 1.